EUVIMEDEUVIMED entdecken
Übersichtsarbeit

P emphigus V ulgaris: U pdate on E tiopathogenesis, O ral M anifestations, and M anagement

Crispian Scully, Stephen J Challacombe

Critical Reviews in Oral Biology & Medicine · 2002-09 · 13 (5) · 397-408

DOI: 10.1177/154411130201300504 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Critical Reviews in Oral Biology & Medicine, online erschienen am 01.09.2002. Verfasst von Crispian Scully und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, Eastman Dental Institute for Oral Health Care Sciences, University College London, University of London, 256 Gray's Inn …. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 179 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pemphigus is a group of potentially life-threatening diseases characterized by cutaneous and mucosal blistering. There is a fairly strong genetic background to pemphigus with linkage to HLA class II alleles. Certain ethnic groups, such as Ashkenazi Jews and those of Mediterranean origin, are especially liable to pemphigus. Pemphigus vulgaris (PV), the most common and important variant, is an autoimmune blistering disease characterized by circulating pathogenic IgG antibodies against desmoglein 3 (Dsg3), about half the patients also having Dsg1 autoantibodies. Oral lesions are initially vesiculobullous but readily rupture, new bullae developing as the older ones rupture and ulcerate. Biopsy of perilesional tissue, with histological and immunostaining examinations, is essential to the diagnosis. Serum autoantibodies to either Dsg1 or Dsg3 are best detected by both normal human skin and monkey esophagus or by enzyme-linked immunosorbent assay (ELISA). Before the introduction of corticosteroids, pemphigus vulgaris was typically fatal mainly from dehydration or secondary systemic infections. Current treatment is largely based on systemic immunosuppression using systemic corticosteroids, with azathioprine, dapsone, methotrexate, cyclophosphamide, and gold as adjuvants or alternatives, but mycophenolate mofetil and intravenous immunoglobulins also appear promising.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Cortex HormonesAnimalsAutoantibodiesAutoantigensCadherinsDesmoglein 1Desmoglein 3EthnicityGenes, MHC Class IIHumansImmunity, CellularImmunosuppressive AgentsOral UlcerPemphigus

Substanzen

Adrenal Cortex HormonesAutoantibodiesAutoantigensCadherinsDSG3 protein, humanDesmoglein 1Desmoglein 3Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Oral Medicine, Eastman Dental Institute for Oral Health Care Sciences, University College London, University of London, 256 Gray's Inn Road, London WC1X 8LD, UK. scully.c@eastman.ucl.ac.uk

Zitieren

APA

Scully, C., & Challacombe, S. J. (2002). P emphigus V ulgaris: U pdate on E tiopathogenesis, O ral M anifestations, and M anagement. Critical Reviews in Oral Biology & Medicine, 13(5), 397-408. https://doi.org/10.1177/154411130201300504

Vancouver

Scully C, Challacombe SJ. P emphigus V ulgaris: U pdate on E tiopathogenesis, O ral M anifestations, and M anagement. Critical Reviews in Oral Biology & Medicine. 2002;13(5):397-408. doi:10.1177/154411130201300504

BibTeX
@article{Scully2002,
  author = {Scully, Crispian and Challacombe, Stephen J},
  title = {P emphigus V ulgaris: U pdate on E tiopathogenesis, O ral M anifestations, and M anagement},
  journal = {Critical Reviews in Oral Biology & Medicine},
  year = {2002},
  volume = {13},
  number = {5},
  pages = {397--408},
  doi = {10.1177/154411130201300504}
}
Kostenlos starten →